The Premier
RBQM Industry
Event

This is where the brightest minds in clinical trials come together to push the boundaries of risk-based quality management (RBQM).

Whether you’re and expert, a rising star, or just RBQM-curious, you’ll be among the first to hear game-changing tech updates and fresh takes on AI, global regulations, and beyond. Stay ahead. Stay sharp. Your competitive edge starts here.

This is where the brightest minds in clinical trials come together to push the boundaries of risk-based quality management (RBQM).

Whether you’re and expert, a rising star, or just RBQM-curious, you’ll be among the first to hear game-changing tech updates and fresh takes on AI, global regulations, and beyond. Stay ahead. Stay sharp. Your competitive edge starts here.

Join us

October 7-8th

What’s RBQMLive?

RBQMLive is the premier virtual event dedicated to RBQM. Held annually, it brings together industry experts, clinical trial professionals, and product innovators, for deep-dive discussions and meaningful networking. Attendees gain exclusive insights into cutting-edge RBQM technology, evolving global regulations, and the latest industry recommendations - equipping them with real, actionable value to apply in their clinical trials and team right away.

Calling All Clinical Trial Professionals

Join The Conversation

2026 marks the sixth annual RBQMLive,
and the conversation keeps growing. Are you ready to be a part of it?

Save the Date:
October 7–8, 2026

Want to Speak at RBQMLive26 or Other CluePoints Events?

We’re looking for industry experts, innovators, and thought leaders to take the virtual stage. Submit your details using the form, and we’ll be in touch to discuss speaking opportunities.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Our Founder and Sponsor:

CluePoints created RBQMLive to give the RBQM community a dedicated space to learn, debate, and advance the science of risk-based quality management. As the founding sponsor, CluePoints brings together the brightest minds in clinical trials, independent of any commercial agenda.

2026 Agenda

Day 1: SESSION #1

RBQM at a Turning Point: From Adoption to Operational Maturity E8 and E11 Potential Expansion

9:00-10:00 AM

Risk-Based Quality Management has achieved widespread adoption, but true operational maturity remains elusive. This keynote examines where the industry stands today, why expectations have shifted, and how regulatory expectations source, including ICH E6(R3), combined with the rapid emergence of AI and real-time oversight are redefining what “good” looks like.

Attendees will gain a clear perspective on the next phase of RBQM, and the organizational capabilities needed to succeed.

Speakers

Speaker TBA

Role, Organization

Speaker TBA

Role, Organization

Day 1: SESSION #2

Beyond Adoption: Proving the Value of a Mature RBQM Program

10:00-11:00 AM

Organizations have largely implemented RBQM, but achieving measurable value requires moving beyond compliance toward operational excellence. This discussion explores how leading sponsors are advancing their RBQM programs, overcoming common barriers, and building mature, scalable risk management practices. Panelists will share lessons learned around governance, organizational change, cross-functional collaboration, and, critically, how they build and defend the business case: the metrics that convince finance and quality leadership that RBQM delivers a measurable return.

Panelists

Speaker TBA

Role, Organization

Speaker TBA

Role, Organization

Speaker TBA

Role, Organization

Day 2: SESSION #3

Trusted AI in Clinical Operations: From Automation to Decision Intelligence

9:00-10:00 AM

AI is rapidly moving from experimentation to practical application across clinical development. This session explores how organizations are implementing AI responsibly while improving efficiency, consistency, and decision-making. Speakers will discuss governance, validation, transparency, auditability, continuous monitoring, and what sponsors need from AI vendors to confidently integrate AI into regulated clinical processes.

Discussion Topics

Speakers

Speaker TBA

Role, Organization

Speaker TBA

Role, Organization

Speaker TBA

Role, Organization

Day 2: SESSION #4

Designing Quality: From Inspection Readiness to Predicting Risk Before First Patient

10:00-11:00 AM

Inspection readiness is no longer about preparing for an audit. It is about continuously understanding and managing quality risk throughout a study. This session explores how organizations are shifting from reactive compliance to predictive quality management, using historical study data and protocol intelligence to identify emerging risk before they affect execution, and increasingly to design risk out at the protocol stage. As protocols become more complex, panelists will discuss how early risk visibility improves planning, oversight, and regulatory confidence.

Discussion Topics

Panelists

Speaker TBA

Role, Organization

Speaker TBA

Role, Organization

Speaker TBA

Role, Organization

Your RBQM Guides

We’re deeply grateful to our expert speakers for sharing their knowledge and perspectives. Special thanks to leaders from Tufts CSDD, Parexel, Deloitte, Syneos Health, and Veeva for delivering cutting-edge insights that are already driving meaningful change across the industry.
More from previous years
More from previous years